黑龙江医学
黑龍江醫學
흑룡강의학
HEILONGJIANG MEDICAL JOURNAL
2015年
6期
610-611
,共2页
孔祥敬%陈永升%周亚丽%尹晓林
孔祥敬%陳永升%週亞麗%尹曉林
공상경%진영승%주아려%윤효림
非霍奇金淋巴瘤%地中海贫血%化疗相关性贫血%益髓生血颗粒
非霍奇金淋巴瘤%地中海貧血%化療相關性貧血%益髓生血顆粒
비곽기금림파류%지중해빈혈%화료상관성빈혈%익수생혈과립
Non-Hodking lymphoma%Thalssemia%Chemotherapy induced anemia%Yisuishengxue granule
目的:观察合并地中海贫血(地贫)对非霍奇金淋巴瘤( NHL)化疗相关性贫血的影响及益髓生血颗粒的保护作用。方法对38例NHL合并地贫患者与38例NHL未合并地贫患者进行回顾性分析,观察第1疗程CHOP方案时化疗过程中的血红蛋白( Hb)水平并进行比较。对38例NHL合并地贫者在接受第2疗程CHOP化疗时随机分为2组,治疗组19例同时应用益髓生血颗粒;对照组单纯接受化疗,观察Hb水平变化。结果合并地贫的NHL患者接受CHOP化疗后平均Hb下降为(8.6±5.2) g/L,与未合并地贫组(5.8±4.4) g/L相比差异有统计学意义( P=0.013)。合并地贫的NHL患者在接受第2疗程CHOP方案化疗时,若治疗组Hb平均下降(2.2±2.3)g/L,对照组为平均下降(4.5±4.1)g/L,差异有统计学意义(P=0.0398)。结论南方地区NHL合并地贫患者并不少见,在接受化疗时贫血更为严重,化疗时使用益髓生血颗粒有一定的保护作用。
目的:觀察閤併地中海貧血(地貧)對非霍奇金淋巴瘤( NHL)化療相關性貧血的影響及益髓生血顆粒的保護作用。方法對38例NHL閤併地貧患者與38例NHL未閤併地貧患者進行迴顧性分析,觀察第1療程CHOP方案時化療過程中的血紅蛋白( Hb)水平併進行比較。對38例NHL閤併地貧者在接受第2療程CHOP化療時隨機分為2組,治療組19例同時應用益髓生血顆粒;對照組單純接受化療,觀察Hb水平變化。結果閤併地貧的NHL患者接受CHOP化療後平均Hb下降為(8.6±5.2) g/L,與未閤併地貧組(5.8±4.4) g/L相比差異有統計學意義( P=0.013)。閤併地貧的NHL患者在接受第2療程CHOP方案化療時,若治療組Hb平均下降(2.2±2.3)g/L,對照組為平均下降(4.5±4.1)g/L,差異有統計學意義(P=0.0398)。結論南方地區NHL閤併地貧患者併不少見,在接受化療時貧血更為嚴重,化療時使用益髓生血顆粒有一定的保護作用。
목적:관찰합병지중해빈혈(지빈)대비곽기금림파류( NHL)화료상관성빈혈적영향급익수생혈과립적보호작용。방법대38례NHL합병지빈환자여38례NHL미합병지빈환자진행회고성분석,관찰제1료정CHOP방안시화료과정중적혈홍단백( Hb)수평병진행비교。대38례NHL합병지빈자재접수제2료정CHOP화료시수궤분위2조,치료조19례동시응용익수생혈과립;대조조단순접수화료,관찰Hb수평변화。결과합병지빈적NHL환자접수CHOP화료후평균Hb하강위(8.6±5.2) g/L,여미합병지빈조(5.8±4.4) g/L상비차이유통계학의의( P=0.013)。합병지빈적NHL환자재접수제2료정CHOP방안화료시,약치료조Hb평균하강(2.2±2.3)g/L,대조조위평균하강(4.5±4.1)g/L,차이유통계학의의(P=0.0398)。결론남방지구NHL합병지빈환자병불소견,재접수화료시빈혈경위엄중,화료시사용익수생혈과립유일정적보호작용。
Objective To observe the effect of thalassemia carrier on the chemotherapy induced anemia in patients with non -Hodking lymphoma(NHL)andprotectionroleofYisuishengxuegranule.Methods 38patientswithNHLcomplicatedwiththalssemiawerestudied. 38 patients with NHL not complicated with thalssemia were selected .Hemoglobin levels among the first course of CHOP chemotherapy were detected .Those patients with thalassemia were further classified into groups in the second course of chemotherapy : for treatement group , Yisuishengxue granules were used together with chemotherapy ,and for observe group ,merely chemotherapy was adapted .Also hemoglobin levels were detected during chemotherapy .Results Through comparing with patients without thalssemia ,hemoglobin decreased level was significantly higher in patients with thalssemia (8.6 ±5.2)g/L vs (5.8 ±4.4)g/L,with significant statistical significance (P=0.013). During the second course of chemotherapy in patients with NHL complicated with thalassemia ,decreased hemoglobin level in patients treated with Yisuishengxue granule was significantly lower than those patients not treated with Yisuishengxue granule (2.2 ±2.3)g/L vs( 4.5 ± 4.1 ) g/L,with significant statistical meaning , P=0.0398.Conclusion Patients′concurrent NHL and thalassemia is common in Southern China.Concurrent thalassemia aggravates chemotherapy induced anemia in patients with NHL .Yisuishenxue granule may alleviate chemo-therapy induced anemia in patients with NHL complicated with thalassemia .